Penghui Zhou

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Venues

EMBO molecular medicine

Cell research

Nature cancer

Signal transduction and targeted therapy

Sun Yat-sen University Cancer Center

University of Michigan (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Sun Yat-sen University Cancer Center Jan 1o 2015

China

Professor :: Cancer Immunoloty Research

Education History

University of Michigan Sep 2o 2003 - Dec 31o 2008

United States

PHD :: Immunology Program

Publications

Yuanzhong Wu, Liwen Zhou, Yezi Zou, Yijun Zhang, Meifang Zhang, Liping Xu, Lisi Zheng, Wenting He, Kuai Yu, Ting Li, Xia Zhang, Zhenxuan Chen, Ruhua Zhang, Penghui Zhou, Nu Zhang, Limin Zheng, Tie-Bang Kang
Disrupting the phase separation of KAT8-IRF1 diminishes PD-L1 expression and promotes antitumor immunity. Nature cancer (2023)
Jingjing He, Xinxin Xiong, Han Yang, Dandan Li, Xuefei Liu, Shuo Li, Shuangye Liao, Siyu Chen, Xizhi Wen, Kuai Yu, Lingyi Fu, Xingjun Dong, Kaiyu Zhu, Xiaojun Xia, Tie-Bang Kang, Chaochao Bian, Xiang Li, Haiping Liu, Peirong Ding, Xiaoshi Zhang, Zhenjiang Liu, Wende Li, Zhi-Xiang Zuo, Penghui Zhou
Defined tumor antigen-specific T cells potentiate personalized TCR-T cell therapy and prediction of immunotherapy response. Cell research 32 (6) (2022)
Xinxin Xiong, Siyu Chen, Jianfei Shen, Hua You, Han Yang, Chao Yan, Ziqian Fang, Jianeng Zhang, Xiuyu Cai, Xingjun Dong, Tiebang Kang, Wende Li, Penghui Zhou
Cannabis suppresses antitumor immunity by inhibiting JAK/STAT signaling in T cells through CNR2. Signal transduction and targeted therapy 7 (1) (2022)
Qian Zhou, Jinxia Liang, Tong Yang, Jin Liu, Bo Li, Yingchang Li, Zhenzhen Fan, Weida Wang, Wensheng Chen, Sujing Yuan, Meng Xu, Qigui Xu, Zhidong Luan, Zhongjun Xia, Penghui Zhou, Yadong Huang, Liang Chen
Carfilzomib modulates tumor microenvironment to potentiate immune checkpoint therapy for cancer. EMBO molecular medicine 14 (1) (2021)
Zhenzhen Fan, Yahui Tian, Zhipeng Chen, Lu Liu, Qian Zhou, Jingjing He, James Coleman, Changjiang Dong, Nan Li, Junqi Huang, Chenqi Xu, Zhimin Zhang, Song Gao, Penghui Zhou, Ke Ding, Liang Chen
Blocking interaction between SHP2 and PD-1 denotes a novel opportunity for developing PD-1 inhibitors. EMBO molecular medicine 12 (6) (2020)
Kuai Yu, Jingjing He, Yongjian Wu, Baosong Xie, Xuefei Liu, Bo Wei, Haibo Zhou, Bingliang Lin, Zhi-Xiang Zuo, Wen Wen, Wen-Xiong Xu, Bin Zou, Lai Wei, Xi Huang, Penghui Zhou
Dysregulated adaptive immune response contributes to severe COVID-19. Cell research 30 (9) (2020)

Penghui Zhou.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Penghui Zhou